These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 6140175)

  • 1. Pharmacological characteristics of dopamine receptors involved in the dual effect of dopamine agonists on yawning behaviour in rats.
    Protais P; Dubuc I; Costentin J
    Eur J Pharmacol; 1983 Oct; 94(3-4):271-80. PubMed ID: 6140175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of drugs acting on central dopamine receptors and cholinoceptors on yawning responses in the rat induced by apomorphine, bromocriptine or physostigmine.
    Zarrindast MR; Poursoltan M
    Br J Pharmacol; 1989 Apr; 96(4):843-8. PubMed ID: 2663110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsychotic substances and dopamine in the rat brain; behavioral studies reveal distinct dopamine receptor systems.
    Van Ree JM; Elands J; Király I; Wolterink G
    Eur J Pharmacol; 1989 Aug; 166(3):441-52. PubMed ID: 2572429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonism of the apomorphine-induced yawning by "atypical" neuroleptics.
    Dubuc I; Protais P; Colboc O; Costentin J
    Neuropharmacology; 1982 Nov; 21(11):1203-6. PubMed ID: 6129594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Climbing and stereotyped behaviours in mice require the stimulation of D-1 dopamine receptors.
    Vasse M; Chagraoui A; Protais P
    Eur J Pharmacol; 1988 Mar; 148(2):221-9. PubMed ID: 2897924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for multiple dopamine receptors involved in the modulation of acetylcholine release in the striatum.
    Hársing LG; Vizi ES
    Pol J Pharmacol Pharm; 1985; 37(3):383-96. PubMed ID: 2866504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of some atypical neuroleptics on apomorphine-induced behaviors as a measure of their relative potencies in blocking presynaptic versus postsynaptic dopamine receptors.
    Robertson A; MacDonald C
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1639-43. PubMed ID: 2874567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of repeated administration of low doses of apomorphine in three behavioural models in the rat.
    Ljungberg T; Ståhle L; Ungerstedt U
    J Neural Transm Park Dis Dement Sect; 1989; 1(3):165-75. PubMed ID: 2775467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that apomorphine and pergolide induce rotation in rats by different actions on D1 and D2 receptor sites.
    Herrera-Marschitz M; Ungerstedt U
    Eur J Pharmacol; 1984 Feb; 98(2):165-76. PubMed ID: 6143675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre- and post-synaptic dopaminergic receptors involved in apomorphine-induced yawning.
    Urba-Holmgren R; Holmgren B; Anias J
    Acta Neurobiol Exp (Wars); 1982; 42(2):115-25. PubMed ID: 6891988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unexpected potentiation by discriminant benzamide derivatives of stereotyped behaviours elicited by dopamine agonists in mice.
    Vasse M; Protais P; Costentin J; Schwartz JC
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Apr; 329(2):108-16. PubMed ID: 4040215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine.
    Breese GR; Baumeister AA; McCown TJ; Emerick SG; Frye GD; Crotty K; Mueller RA
    J Pharmacol Exp Ther; 1984 Nov; 231(2):343-54. PubMed ID: 6149306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drugs affecting dopamine neurons and yawning behavior.
    Mogilnicka E; Klimek V
    Pharmacol Biochem Behav; 1977 Oct; 7(4):303-5. PubMed ID: 200963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yawning elicited by systemic and intrastriatal injection of piribedil and apomorphine in the rat.
    Dourish CT; Cooper SJ; Philips SR
    Psychopharmacology (Berl); 1985; 86(1-2):175-81. PubMed ID: 2991964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism of the amphetamine cue by both classical and atypical antipsychotic drugs.
    Nielsen EB; Jepsen SA
    Eur J Pharmacol; 1985 May; 111(2):167-76. PubMed ID: 2862045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The discriminant dopamine antagonist property of benzamides is observed at various times after their systemic or intracerebroventricular administration.
    Protais P; Hermier C; Costentin J
    Neuropharmacology; 1985 Sep; 24(9):861-7. PubMed ID: 2865694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine receptor antagonist properties of S 14506, 8-OH-DPAT, raclopride and clozapine in rodents.
    Protais P; Chagraoui A; Arbaoui J; Mocaër E
    Eur J Pharmacol; 1994 Dec; 271(1):167-77. PubMed ID: 7698199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial agonistic effects of OPC-14597, a potential antipsychotic agent, on yawning behavior in rats.
    Fujikawa M; Nagashima M; Inoue T; Yamada K; Furukawa T
    Pharmacol Biochem Behav; 1996 Apr; 53(4):903-9. PubMed ID: 8801596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of different dopamine receptors in rat diphasic motility response to apomorphine.
    Vaccheri A; Dall'Olio R; Gandolfi O; Montanaro N
    Psychopharmacology (Berl); 1986; 89(3):265-8. PubMed ID: 2873607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apomorphine-induced yawning in rats is abolished by bilateral 6-hydroxydopamine lesions of the substantia nigra.
    Stoessl AJ; Dourish CT; Iversen SD
    Psychopharmacology (Berl); 1987; 93(3):336-42. PubMed ID: 3124163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.